CELCUITY INC. Research and Development Expense
CELCUITY INC. (CELC) reported Research and Development Expense of $31.08 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:ResearchAndDevelopmentExpense · last filed 2026-08-13
- CELCUITY INC. research and development expense for the quarter ending 2026-06-30 was $31.08M, a 14.66% decline year-over-year.
- CELCUITY INC. research and development expense for the quarter ending 2026-03-31 was $33.06M, a 11.10% increase year-over-year.
- CELCUITY INC. research and development expense for the quarter ending 2025-12-31 was $37.63M, a 12.43% increase year-over-year.
- CELCUITY INC. research and development expense for the quarter ending 2025-09-30 was $34.91M, a 26.56% increase year-over-year.
- CELCUITY INC. research and development expense for fiscal 2025 was $145.00M, a 39.15% increase from fiscal 2024.
- CELCUITY INC. research and development expense for fiscal 2024 was $104.20M, a 71.97% increase from fiscal 2023.
- CELCUITY INC. research and development expense for fiscal 2023 was $60.59M, a 71.71% increase from fiscal 2022.
- CELCUITY INC. research and development expense for fiscal 2022 was $35.29M, a 37.00% increase from fiscal 2021.
| Period end | Research and Development Expense 3 month | Research and Development Expense 3 month as first filed | Research and Development Expense 6 month | Research and Development Expense 6 month as first filed | Research and Development Expense 9 month | Research and Development Expense 9 month as first filed | Research and Development Expense 12 month | Research and Development Expense 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $31.08M 10-Q · filed 2026-08-13 | $64.14M 10-Q · filed 2026-08-13 | $101.77M derived: sum of 3 quarters · filed 2026-08-13 | $136.69M derived: sum of 4 quarters · filed 2026-08-13 | ||||
| 2026-03-31 | $33.06M 10-Q · filed 2026-05-14 | $70.69M derived: sum of 2 quarters · filed 2026-05-14 | $105.61M derived: sum of 3 quarters · filed 2026-05-14 | $142.02M derived: sum of 4 quarters · filed 2026-08-13 | ||||
| 2025-12-31 | $37.63M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-26 | $72.55M derived: sum of 2 quarters · filed 2026-03-26 | $108.96M derived: sum of 3 quarters · filed 2026-08-13 | $145.00M 10-K · filed 2026-03-26 | ||||
| 2025-09-30 | $34.91M 10-Q · filed 2025-11-13 | $71.33M derived: sum of 2 quarters · filed 2026-08-13 | $107.36M 10-Q · filed 2025-11-13 | $134.56M derived: sum of 4 quarters · filed 2026-08-13 | ||||
| 2025-06-30 | $36.41M 10-Q · filed 2026-08-13 | $40.22M 10-Q · filed 2025-08-14 | $66.17M 10-Q · filed 2026-08-13 | $72.45M 10-Q · filed 2025-08-14 | $99.64M derived: sum of 3 quarters · filed 2026-08-13 | $127.23M derived: sum of 4 quarters · filed 2026-08-13 | ||
| 2025-03-31 | $29.76M 10-Q · filed 2026-05-14 | $32.23M 10-Q · filed 2025-05-15 | $63.23M derived: sum of 2 quarters · filed 2026-05-14 | $90.82M derived: sum of 3 quarters · filed 2026-05-14 | $113.32M derived: sum of 4 quarters · filed 2026-05-14 | |||
| 2024-12-31 | $33.47M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-26 | $61.06M derived: sum of 2 quarters · filed 2026-03-26 | $83.56M derived: sum of 3 quarters · filed 2026-03-26 | $104.20M 10-K · filed 2026-03-26 | $104.20M 10-K · filed 2025-03-31 | |||
| 2024-09-30 | $27.59M 10-Q · filed 2025-11-13 | $27.59M 10-Q · filed 2024-11-14 | $50.09M derived: sum of 2 quarters · filed 2025-11-13 | $70.73M 10-Q · filed 2025-11-13 | $70.73M 10-Q · filed 2024-11-14 | $88.81M derived: sum of 4 quarters · filed 2025-11-13 | ||
| 2024-06-30 | $22.50M 10-Q · filed 2025-08-14 | $22.50M 10-Q · filed 2024-08-14 | $43.15M 10-Q · filed 2025-08-14 | $43.14M 10-Q · filed 2024-08-14 | $61.23M derived: sum of 3 quarters · filed 2025-08-14 | $78.71M derived: sum of 4 quarters · filed 2025-08-14 | ||
| 2024-03-31 | $20.65M 10-Q · filed 2025-05-15 | $20.65M 10-Q · filed 2024-05-15 | $38.73M derived: sum of 2 quarters · filed 2025-05-15 | $56.22M derived: sum of 3 quarters · filed 2025-05-15 | $69.96M derived: sum of 4 quarters · filed 2025-05-15 | |||
| 2023-12-31 | $18.08M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | $35.57M derived: sum of 2 quarters · filed 2025-03-31 | $49.32M derived: sum of 3 quarters · filed 2025-03-31 | $60.59M 10-K · filed 2025-03-31 | ||||
| 2023-09-30 | $17.49M 10-Q · filed 2024-11-14 | $31.23M derived: sum of 2 quarters · filed 2024-11-14 | $42.51M 10-Q · filed 2024-11-14 | $53.12M derived: sum of 4 quarters · filed 2024-11-14 | ||||
| 2023-06-30 | $13.75M 10-Q · filed 2024-08-14 | $25.02M 10-Q · filed 2024-08-14 | $35.63M derived: sum of 3 quarters · filed 2024-08-14 | $45.25M derived: sum of 4 quarters · filed 2024-08-14 | ||||
| 2023-03-31 | $11.28M 10-Q · filed 2024-05-15 | $21.88M derived: sum of 2 quarters · filed 2024-05-15 | $31.50M derived: sum of 3 quarters · filed 2024-05-15 | $39.87M derived: sum of 4 quarters · filed 2024-05-15 | ||||
| 2022-12-31 | $10.60M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-27 | $20.23M derived: sum of 2 quarters · filed 2024-03-27 | $28.59M derived: sum of 3 quarters · filed 2024-03-27 | $35.29M 10-K · filed 2024-03-27 | ||||
| 2022-09-30 | $9.62M 10-Q · filed 2023-11-13 | $17.99M derived: sum of 2 quarters · filed 2023-11-13 | $24.69M 10-Q · filed 2023-11-13 | $30.18M derived: sum of 4 quarters · filed 2023-11-13 | ||||
| 2022-06-30 | $8.37M 10-Q · filed 2023-08-11 | $15.06M 10-Q · filed 2023-08-11 | $20.56M derived: sum of 3 quarters · filed 2023-08-11 | $25.52M derived: sum of 4 quarters · filed 2023-08-11 | ||||
| 2022-03-31 | $6.70M 10-Q · filed 2023-05-15 | $12.19M derived: sum of 2 quarters · filed 2023-05-15 | $17.15M derived: sum of 3 quarters · filed 2023-05-15 | $30.22M derived: sum of 4 quarters · filed 2023-05-15 | ||||
| 2021-12-31 | $5.49M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-23 | $10.45M derived: sum of 2 quarters · filed 2023-03-23 | $23.52M derived: sum of 3 quarters · filed 2023-03-23 | $25.76M 10-K · filed 2023-03-23 | ||||
| 2021-09-30 | $4.96M 10-Q · filed 2022-11-10 | $18.03M derived: sum of 2 quarters · filed 2022-11-10 | $20.27M 10-Q · filed 2022-11-10 | $22.37M derived: sum of 4 quarters · filed 2022-11-10 | ||||
| 2021-06-30 | $13.07M 10-Q · filed 2022-08-12 | $15.31M 10-Q · filed 2022-08-12 | $17.41M derived: sum of 3 quarters · filed 2022-08-12 | $19.38M derived: sum of 4 quarters · filed 2022-08-12 | ||||
| 2021-03-31 | $2.24M 10-Q · filed 2022-05-16 | $4.34M derived: sum of 2 quarters · filed 2022-05-16 | $6.31M derived: sum of 3 quarters · filed 2022-05-16 | $8.07M derived: sum of 4 quarters · filed 2022-05-16 | ||||
| 2020-12-31 | $2.11M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-23 | $4.07M derived: sum of 2 quarters · filed 2022-03-23 | $5.84M derived: sum of 3 quarters · filed 2022-03-23 | $7.68M 10-K · filed 2022-03-23 | ||||
| 2020-09-30 | $1.96M 10-Q · filed 2021-11-09 | $3.73M derived: sum of 2 quarters · filed 2021-11-09 | $5.58M 10-Q · filed 2021-11-09 | $7.07M derived: sum of 4 quarters · filed 2021-11-09 | ||||
| 2020-06-30 | $1.77M 10-Q · filed 2021-08-11 | $3.61M 10-Q · filed 2021-08-11 | $5.11M derived: sum of 3 quarters · filed 2021-08-11 | $6.82M derived: sum of 4 quarters · filed 2021-08-11 | ||||
| 2020-03-31 | $1.85M 10-Q · filed 2021-05-10 | $3.34M derived: sum of 2 quarters · filed 2021-05-10 | $5.06M derived: sum of 3 quarters · filed 2021-05-10 | $6.53M derived: sum of 4 quarters · filed 2021-05-10 | ||||
| 2019-12-31 | $1.50M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-16 | $3.21M derived: sum of 2 quarters · filed 2021-02-16 | $4.68M derived: sum of 3 quarters · filed 2021-02-16 | $6.27M 10-K · filed 2021-02-16 | ||||
| 2019-09-30 | $1.71M 10-Q · filed 2020-11-09 | $3.18M derived: sum of 2 quarters · filed 2020-11-09 | $4.77M 10-Q · filed 2020-11-09 | $6.41M derived: sum of 4 quarters · filed 2020-11-09 | ||||
| 2019-06-30 | $1.47M 10-Q/A · filed 2020-08-11 | $3.06M 10-Q/A · filed 2020-08-11 | $4.70M derived: sum of 3 quarters · filed 2020-08-11 | $6.29M derived: sum of 4 quarters · filed 2020-08-11 | ||||
| 2019-03-31 | $1.59M 10-Q · filed 2020-05-07 | $3.23M derived: sum of 2 quarters · filed 2020-05-07 | $4.82M derived: sum of 3 quarters · filed 2020-05-07 | $6.37M derived: sum of 4 quarters · filed 2020-05-07 | ||||
| 2018-12-31 | $1.63M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-13 | $3.23M derived: sum of 2 quarters · filed 2020-03-13 | $4.78M derived: sum of 3 quarters · filed 2020-03-13 | $6.33M 10-K · filed 2020-03-13 | ||||
| 2018-09-30 | $1.60M 10-Q · filed 2019-11-07 | $3.15M derived: sum of 2 quarters · filed 2019-11-07 | $4.69M 10-Q · filed 2019-11-07 | $6.09M derived: sum of 4 quarters · filed 2019-11-07 | ||||
| 2018-06-30 | $1.55M 10-Q · filed 2019-08-08 | $3.09M 10-Q · filed 2019-08-08 | $4.50M derived: sum of 3 quarters · filed 2019-08-08 | $5.86M derived: sum of 4 quarters · filed 2019-08-08 | ||||
| 2018-03-31 | $1.55M 10-Q · filed 2019-05-07 | $2.95M derived: sum of 2 quarters · filed 2019-05-07 | $4.31M derived: sum of 3 quarters · filed 2019-05-07 | $5.62M derived: sum of 4 quarters · filed 2019-05-07 | ||||
| 2017-12-31 | $1.40M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-01 | $2.77M derived: sum of 2 quarters · filed 2019-03-01 | $4.07M derived: sum of 3 quarters · filed 2019-03-01 | $4.98M 10-K · filed 2019-03-01 | ||||
| 2017-09-30 | $1.36M 10-Q · filed 2018-11-13 | $2.67M derived: sum of 2 quarters · filed 2018-11-13 | $3.58M 10-Q · filed 2018-11-13 | $4.42M derived: sum of 4 quarters · filed 2018-11-13 | ||||
| 2017-06-30 | $1.30M 10-Q · filed 2018-08-09 | $2.21M 10-Q · filed 2018-08-09 | $3.05M derived: sum of 3 quarters · filed 2018-08-09 | $3.87M derived: sum of 4 quarters · filed 2018-08-09 | ||||
| 2017-03-31 | $908.77K 10-Q · filed 2018-05-14 | $1.75M derived: sum of 2 quarters · filed 2018-05-14 | $2.56M derived: sum of 3 quarters · filed 2018-05-14 | |||||
| 2016-12-31 | $839.90K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-15 | $1.65M derived: sum of 2 quarters · filed 2018-03-15 | $3.06M 10-K · filed 2018-03-15 | |||||
| 2016-09-30 | $812.80K 10-Q · filed 2017-12-01 | $2.22M 10-Q · filed 2017-12-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| VERACYTE, INC. (VCYT) | United States | $3.904B | 41.21 |
| CareDx, Inc. (CDNA) | United States | $3.174B | 13.21 |
| GRAIL, Inc. (GRAL) | United States | $5.591B | -7.78 |
| RadNet, Inc. (RDNT) | United States | $5.611B | -229.65 |
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |
| Personalis, Inc. (PSNL) | United States | $1.769B | -13.30 |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| BIODESIX INC (BDSX) | United States | $0.312B |